Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Balain interesting post was this also posted on
View:
Post by edrose on Feb 07, 2022 3:19pm

Balain interesting post was this also posted on

Zymeworks site

this will come out during questioning under oath at discovery in 2022 even if they try to delay tactics
judge will have say on defendants tactics 

after all facts presented  legal decisions will be rendered and truth will come out
Comment by balain on Feb 07, 2022 3:35pm
You bet edrose, posted on Zymeworks as well! it's good to have a better understanding of who we are dealing with. Zymeworks shareholders may not have a clue of Galbraith's track record at Liminal since they obviously skipped that part during the introductions at Zymeworks. He is welcome to clarify the Fairhaven deal in public if he wishes... balain
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities